Flexion Therapeutics
Biopharmaceutical company focused on advancing innovative, local therapies for the treatment of patients with musculoskeletal conditions, beginning with osteoarthritis (OA), a type of degenerative arthritis.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD583m (Public information from Oct 2021)
Share price
$9.12 FLXN
Woburn Massachusetts (HQ)
Authorizing premium user...